Therefore, we grouped the subset of patients with antibodies against neurofascin, contactin1, and Caspr under the term “seropositive CIDP.” While antibodies to gangliosides are frequently found in GBS, such autoantibodies are typically not found in CIDP (6). Here, NFASC is linked to chronic inflammatory demyelinating polyradiculoneuropathy.